4//SEC Filing
Artal Group S.A. 4
Accession 0000950170-24-059789
CIK 0001062822other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 5:17 PM ET
Size
30.4 KB
Accession
0000950170-24-059789
Insider Transaction Report
Form 4
ARTAL INTERNATIONAL SCA
Director10% Owner
Transactions
- Award
Series A Convertible Preferred Stock
2024-05-10$108.50/sh+1,150,922$124,875,037→ 1,150,922 total(indirect: See Footnotes)→ Common Stock (57,546,100 underlying) - Exercise/Conversion
Common Stock
2024-05-10+57,546,100→ 136,180,481 total(indirect: See Footnotes) - Exercise/Conversion
Series A Convertible Preferred Stock
2024-05-10−1,150,922→ 0 total(indirect: See Footnotes)→ Common Stock (57,546,100 underlying)
Holdings
- 3,516,214(indirect: See Footnotes)
Common Stock
- 35,402,689(indirect: See Footnotes)
Common Stock
Invus Public Equities, LP
Director10% Owner
Transactions
- Award
Series A Convertible Preferred Stock
2024-05-10$108.50/sh+1,150,922$124,875,037→ 1,150,922 total(indirect: See Footnotes)→ Common Stock (57,546,100 underlying) - Exercise/Conversion
Common Stock
2024-05-10+57,546,100→ 136,180,481 total(indirect: See Footnotes) - Exercise/Conversion
Series A Convertible Preferred Stock
2024-05-10−1,150,922→ 0 total(indirect: See Footnotes)→ Common Stock (57,546,100 underlying)
Holdings
- 35,402,689(indirect: See Footnotes)
Common Stock
- 3,516,214(indirect: See Footnotes)
Common Stock
Wittouck Amaury
Director10% Owner
Transactions
- Award
Series A Convertible Preferred Stock
2024-05-10$108.50/sh+1,150,922$124,875,037→ 1,150,922 total(indirect: See Footnotes)→ Common Stock (57,546,100 underlying) - Exercise/Conversion
Series A Convertible Preferred Stock
2024-05-10−1,150,922→ 0 total(indirect: See Footnotes)→ Common Stock (57,546,100 underlying) - Exercise/Conversion
Common Stock
2024-05-10+57,546,100→ 136,180,481 total(indirect: See Footnotes)
Holdings
- 3,516,214(indirect: See Footnotes)
Common Stock
- 35,402,689(indirect: See Footnotes)
Common Stock
Stichting Administratiekantoor Westend
Director10% Owner
Transactions
- Award
Series A Convertible Preferred Stock
2024-05-10$108.50/sh+1,150,922$124,875,037→ 1,150,922 total(indirect: See Footnotes)→ Common Stock (57,546,100 underlying) - Exercise/Conversion
Series A Convertible Preferred Stock
2024-05-10−1,150,922→ 0 total(indirect: See Footnotes)→ Common Stock (57,546,100 underlying) - Exercise/Conversion
Common Stock
2024-05-10+57,546,100→ 136,180,481 total(indirect: See Footnotes)
Holdings
- 35,402,689(indirect: See Footnotes)
Common Stock
- 3,516,214(indirect: See Footnotes)
Common Stock
Invus Public Equities Advisors, LLC
Director10% Owner
Transactions
- Exercise/Conversion
Common Stock
2024-05-10+57,546,100→ 136,180,481 total(indirect: See Footnotes) - Exercise/Conversion
Series A Convertible Preferred Stock
2024-05-10−1,150,922→ 0 total(indirect: See Footnotes)→ Common Stock (57,546,100 underlying) - Award
Series A Convertible Preferred Stock
2024-05-10$108.50/sh+1,150,922$124,875,037→ 1,150,922 total(indirect: See Footnotes)→ Common Stock (57,546,100 underlying)
Holdings
- 35,402,689(indirect: See Footnotes)
Common Stock
- 3,516,214(indirect: See Footnotes)
Common Stock
Invus, L.P.
10% Owner
Transactions
- Exercise/Conversion
Common Stock
2024-05-10+57,546,100→ 136,180,481 total(indirect: See Footnotes) - Exercise/Conversion
Series A Convertible Preferred Stock
2024-05-10−1,150,922→ 0 total(indirect: See Footnotes)→ Common Stock (57,546,100 underlying) - Award
Series A Convertible Preferred Stock
2024-05-10$108.50/sh+1,150,922$124,875,037→ 1,150,922 total(indirect: See Footnotes)→ Common Stock (57,546,100 underlying)
Holdings
- 3,516,214(indirect: See Footnotes)
Common Stock
- 35,402,689(indirect: See Footnotes)
Common Stock
Artal International Management S.A.
Director10% Owner
Transactions
- Exercise/Conversion
Common Stock
2024-05-10+57,546,100→ 136,180,481 total(indirect: See Footnotes) - Award
Series A Convertible Preferred Stock
2024-05-10$108.50/sh+1,150,922$124,875,037→ 1,150,922 total(indirect: See Footnotes)→ Common Stock (57,546,100 underlying) - Exercise/Conversion
Series A Convertible Preferred Stock
2024-05-10−1,150,922→ 0 total(indirect: See Footnotes)→ Common Stock (57,546,100 underlying)
Holdings
- 3,516,214(indirect: See Footnotes)
Common Stock
- 35,402,689(indirect: See Footnotes)
Common Stock
Invus Advisors, L.L.C.
10% Owner
Transactions
- Exercise/Conversion
Common Stock
2024-05-10+57,546,100→ 136,180,481 total(indirect: See Footnotes) - Award
Series A Convertible Preferred Stock
2024-05-10$108.50/sh+1,150,922$124,875,037→ 1,150,922 total(indirect: See Footnotes)→ Common Stock (57,546,100 underlying) - Exercise/Conversion
Series A Convertible Preferred Stock
2024-05-10−1,150,922→ 0 total(indirect: See Footnotes)→ Common Stock (57,546,100 underlying)
Holdings
- 3,516,214(indirect: See Footnotes)
Common Stock
- 35,402,689(indirect: See Footnotes)
Common Stock
ARTAL GROUP S A
Director10% Owner
Transactions
- Exercise/Conversion
Common Stock
2024-05-10+57,546,100→ 136,180,481 total(indirect: See Footnotes) - Exercise/Conversion
Series A Convertible Preferred Stock
2024-05-10−1,150,922→ 0 total(indirect: See Footnotes)→ Common Stock (57,546,100 underlying) - Award
Series A Convertible Preferred Stock
2024-05-10$108.50/sh+1,150,922$124,875,037→ 1,150,922 total(indirect: See Footnotes)→ Common Stock (57,546,100 underlying)
Holdings
- 35,402,689(indirect: See Footnotes)
Common Stock
- 3,516,214(indirect: See Footnotes)
Common Stock
WESTEND SA
Director10% Owner
Transactions
- Exercise/Conversion
Common Stock
2024-05-10+57,546,100→ 136,180,481 total(indirect: See Footnotes) - Award
Series A Convertible Preferred Stock
2024-05-10$108.50/sh+1,150,922$124,875,037→ 1,150,922 total(indirect: See Footnotes)→ Common Stock (57,546,100 underlying) - Exercise/Conversion
Series A Convertible Preferred Stock
2024-05-10−1,150,922→ 0 total(indirect: See Footnotes)→ Common Stock (57,546,100 underlying)
Holdings
- 3,516,214(indirect: See Footnotes)
Common Stock
- 35,402,689(indirect: See Footnotes)
Common Stock
Footnotes (6)
- [F1]On March 13, 2024, Artal International S.C.A. acquired 1,150,922 shares of Series A convertible preferred stock, $0.01 par value per share (the "Preferred Stock") of the Issuer at a price of $108.50 per share. Each share of Preferred Stock would automatically convert into 50 shares of the Issuer's common stock, par value $0.001 per share (the "Common Stock") upon receipt of shareholder approval and the satisfaction of certain other conditions (the "Conditions"); however, absent the satisfaction of such conditions, the shares were not convertible and as such, the Preferred Stock was originally reported on Table I. On May 10, 2024, all Conditions were met, and the 1,150,922 shares of Preferred Stock became derivative securities and automatically converted into 57,546,100 shares of Issuer Common Stock.
- [F2]These securities are directly held by Artal International S.C.A.
- [F3]These securities are directly held by Invus Public Equities, L.P.
- [F4]These securities are directly held by Invus, L.P.
- [F5]Invus Public Equities Advisors, LLC is the general partner of Invus Public Equities, L.P., and Invus Advisors, L.L.C. is the general partner of Invus, L.P. The Geneva branch of Artal International S.C.A. is the managing member of Invus Public Equities Advisors, LLC. Artal International S.C.A. is the managing member of Invus Advisors, L.L.C. The managing partner of Artal International S.C.A. is Artal International Management S.A. The sole stockholder of Artal International Management S.A. is Artal Group S.A. The parent company of Artal Group S.A. is Westend S.A. The majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend (the "Stichting"). Mr. Amaury Wittouck is the sole member of the board of the Stichting.
- [F6]Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC.
CIK 0001062822
Entity typeother
IncorporatedLuxembourg
Related Parties
1- filerCIK 0001053906
Filing Metadata
- Form type
- 4
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 5:17 PM ET
- Size
- 30.4 KB